Immunologic Research

, Volume 65, Issue 1, pp 370–374 | Cite as

New automated indirect immunofluorescent antinuclear antibody testing compares well with established manual immunofluorescent screening and titration for antinuclear antibody on HEp-2 cells

  • M. Daves
  • J. Blecken
  • T. Matthias
  • A. Frey
  • V. Perkmann
  • A. Dall´ Acqua
  • A. Joos
  • S. Platzgummer
Mechanism in Autoimmunity

Abstract

The IIF using the HEp-2 cell substrate should be still considered the “gold standard” techniques for determination of antinuclear antibody (ANA). Standardization and automation can be considered to be still in progress. Aim of this study was to evaluate the performance of the commercially automated indirect immunofluorescent antinuclear HEp-2 antibody assay. The study was designed to compare two commercially available HEp-2 ANA by indirect immunofluorescent antibody assays using a sensitivity panel (120 clinically determined patients) and a specificity panel consisting of 78 clinically confirmed negative patients. We compared the NOVA View® system [INOVA Diagnostics San Diego, USA] with the new HELIOS Processor from AESKU Systems/AESKU.Diagnostics (Wendelsheim, Germany) to assess their capability for screening, pattern recognition and titration of the samples. These automated methods were directly compared to manual reading of the same processed slides on respective microscopes and also compared with the known clinical information. The results of the two automated methods were in very good agreement with recognizing negative and positive samples. The HELIOS system detected 188 samples correctly as negative or positive versus 187 detected by the NOVA View® system. The diagnostic sensitivity of the systems was 95.8 versus 96.7 % for HELIOS and NOVA View®, respectively. The systems exhibited a diagnostic specificity of 93.5 % for the HELIOS system and 91.0 % for the NOVA View®. Both systems are suitable for fast and reliable detection of positivity/negativity due to their high sensitivity and will lead to a further increase of standardization in autoimmunity.

Keywords

Antinuclear antibody Autoimmune diseases Indirect immunofluorescent techniques HEp-2 cell Automated systems 

Notes

Compliance with ethical standards

Conflict of interest

M. Daves, V. Perkmann, A. Dall´Acqua, A. Joos and S. Platzgummer declare no conflict of interest.

References

  1. 1.
    Fritzler MJ. Toward a new autoantibody diagnostic orthodoxy: understanding the bad, good and indifferent. Autoimmun Highlights. 2012;3:51–8.CrossRefGoogle Scholar
  2. 2.
    Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F, et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol. 2002;117:316–24.CrossRefPubMedGoogle Scholar
  3. 3.
    Meroni PL, Schur PH. ANA screening an old test with new recommendations. Ann Rheum Dis. 2010;69:1420–2.CrossRefPubMedGoogle Scholar
  4. 4.
    Wiik AS, Bizzaro N. Missing links in high quality diagnostics of inflammatory systemic rheumatic diseases. Autoimmun Highlights. 2012;3:35–49.CrossRefGoogle Scholar
  5. 5.
    Solomon DH, Kavanaugh AJ, Schur PH. The ACR Ad hoc Committee on immunologic testing guidelines. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum. 2002;47:434–44.CrossRefPubMedGoogle Scholar
  6. 6.
    Gonzales DA, de Leon AC, Perez MDCR, Diaz BB, Hernandez AG, Garcia A, et al. Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens. J Immunol Methods. 2010;360:89–95.CrossRefGoogle Scholar
  7. 7.
    Sack U, Knoechner S, Warschkau H, Pigia U, Emmrich F, Kamprad M. Computer-assisted classification of Hep-2 immunofluorescence patterns in autoimmune diagnostics. Autoimmun Rev. 2003;2:298–304.CrossRefPubMedGoogle Scholar
  8. 8.
    Hu V, Murphy RF. Automated interpretation of subcellular patterns from immunofluorescence microscopy. J Immunol Methods. 2004;290:93–105.CrossRefPubMedGoogle Scholar
  9. 9.
    Rigon A, Soda P, Zennaro D, Iannello G, Afeltra A. Indirect immunofluorescence testing: in autoimmune diseases: assessment of digital images for diagnostic purpose. Cytom B. 2007;72B:472–7.CrossRefGoogle Scholar
  10. 10.
    Tozzoli R, D`Aurizio F, Villalta D, Bizzaro N. Automation, consolidation, and integration in autoimmune diagnostics. Autoimmun Highlights. 2015;6:1–6.CrossRefGoogle Scholar
  11. 11.
    Gelpí C, Pérez E, Roldan C. Efficiency of a solid-phase chemiluminescence immunoassay for detection of antinuclear and cytoplasmic autoantibodies compared with gold standard immunoprecipitation. Autoimmun Highlights. 2014;5:47–54.CrossRefGoogle Scholar
  12. 12.
    Tozzoli R, Antico A, Porcelli B, Bassetti D. Automation in indirect immunofluorescence testing: a new step in the evolution of the autoimmunology laboratory. Autoimmun Highlights. 2012;3:59–65.CrossRefGoogle Scholar
  13. 13.
    Bizzaro N, Antico A, Platzgummer S, Tonutti E, Bassetti D, Pesente F, Tozzoli R, Tampoia M, Villalta D. Automated antinuclear immunofluorescence antibody screening: a comparative study of sic computer-aided diagnostic systems. Autoimmun Rev. 2014;13(9):292–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Fritzler MJ. The antinuclear antibody test: last or lasting gasp? Arthritis Rheum. 2011;63:19–22.CrossRefPubMedGoogle Scholar
  15. 15.
    Copple SS, Rashelles Giles S, Jaskowski TD, Gardiner AE, Wilson AM, Hill HR. Screening for IgG antinuclear antibodies by HEp-2 indirect fluorescent antibody assay and the need for standardization. Am J Clin Pathol. 2012;137:825–30.CrossRefPubMedGoogle Scholar
  16. 16.
    Wiik AS, Hoier Madsen M, Forslid J, Charles P, Meyeowitsch SCL. 70 a uniform fine grainy staining of the nucleoplasma and the chromosomal areas of metaphase and telophase cells, often with accentuated positive nucleoli.®®. J Autoimmun. 2010;35:276–90.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • M. Daves
    • 1
  • J. Blecken
    • 2
  • T. Matthias
    • 2
  • A. Frey
    • 2
  • V. Perkmann
    • 1
  • A. Dall´ Acqua
    • 1
  • A. Joos
    • 1
  • S. Platzgummer
    • 1
  1. 1.Clinical Pathology LaboratoryHospital of MeranoMeranoItaly
  2. 2.AESKU.DIAGNOSTICSWendelsheimGermany

Personalised recommendations